Target Group Inc. (CBDY) stock
CBDYOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $431.92KP/E –Yield –
Target total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Target's total debt was $7.33M at Jun 30, 2026. For fiscal 2025 it was $7.60M, up 5.0% from the year before. The highest annual figure on record is $8.36M in fiscal 2021.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.60M | +5.0% |
| FY2024 | Dec 31, 2024 | $7.24M | -8.1% |
| FY2023 | Dec 31, 2023 | $7.88M | +2.4% |
| FY2022 | Dec 31, 2022 | $7.69M | -8.0% |
| FY2021 | Dec 31, 2021 | $8.36M | +0.4% |
| FY2020 | Dec 31, 2020 | $8.33M | +66501.9% |
| FY2015 | Dec 31, 2015 | $12.50K | – |
| FY2014 | Dec 31, 2014 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $7.33M | -4.0% |
| Q1 FY2026 | Mar 31, 2026 | $7.48M | +3.1% |
| Q4 FY2025 | Dec 31, 2025 | $7.60M | +5.0% |
| Q3 FY2025 | Sep 30, 2025 | $7.49M | -3.0% |
| Q2 FY2025 | Jun 30, 2025 | $7.64M | +0.3% |
| Q1 FY2025 | Mar 31, 2025 | $7.25M | -5.7% |
| Q4 FY2024 | Dec 31, 2024 | $7.24M | -8.1% |
| Q3 FY2024 | Sep 30, 2024 | $7.72M | +0.2% |
| Q2 FY2024 | Jun 30, 2024 | $7.61M | -3.3% |
| Q1 FY2024 | Mar 31, 2024 | $7.69M | -0.1% |
| Q4 FY2023 | Dec 31, 2023 | $7.88M | +2.4% |
| Q3 FY2023 | Sep 30, 2023 | $7.71M | +1.4% |
| Q2 FY2023 | Jun 30, 2023 | $7.87M | -2.7% |
| Q1 FY2023 | Mar 31, 2023 | $7.70M | -9.2% |
| Q4 FY2022 | Dec 31, 2022 | $7.69M | -8.0% |
| Q3 FY2022 | Sep 30, 2022 | $7.60M | -8.6% |
| Q2 FY2022 | Jun 30, 2022 | $8.09M | -5.4% |
| Q1 FY2022 | Mar 31, 2022 | $8.48M | +0.6% |
| Q4 FY2021 | Dec 31, 2021 | $8.36M | +0.4% |
| Q3 FY2021 | Sep 30, 2021 | $8.32M | +4.7% |
| Q2 FY2021 | Jun 30, 2021 | $8.55M | +68316.6% |
| Q1 FY2021 | Mar 31, 2021 | $8.43M | – |
| Q4 FY2020 | Dec 31, 2020 | $8.33M | – |
| Q3 FY2020 | Sep 30, 2020 | $7.95M | – |
| Q4 FY2015 | Dec 31, 2015 | $12.50K | – |
See a number that looks wrong?